Register      Login
Public Health Research and Practice Public Health Research and Practice Society
The peer-reviewed journal of the Sax Institute
RESEARCH ARTICLE (Open Access)

‘What about vaping?’ Exploring the facilitators and barriers experienced by health professionals in offering vaping cessation support − a scoping review

Lincan Caroline Tan A , Larisa Ariadne Justine Barnes B C * , Jo Longman B C and Megan Passey B C
+ Author Affiliations
- Author Affiliations

A The University of Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Science Rd, Camperdown, NSW 2020, Australia.

B The Daffodil Centre, Faculty of Medicine and Health, The University of Sydney, Level 5, 1 King St, Newtown, NSW 2042, Australia.

C University Centre for Rural Health, Faculty of Medicine and Health, The University of Sydney, 61 Uralba St, Lismore, NSW 2480, Australia.

* Correspondence to: larisa.barnes@sydney.edu.au

Public Health Research and Practice 35, PU24013 https://doi.org/10.1071/PU24013
Submitted: 4 June 2024  Accepted: 30 September 2024  Published: 9 May 2025

© 2025 The Author(s) (or their employer(s)). Published by CSIRO Publishing on behalf of the Sax Institute. This is an open access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND)

Abstract

Objectives and importance of study

To summarise current evidence on the facilitators and barriers to offering vaping cessation support from the perspective of health professionals (HPs) with client-facing roles.

Study type

A scoping review following the Joanna Briggs Institute methodology.

Methods

Six databases were searched for relevant peer-reviewed articles published in English between 2003 and 2024. All articles were screened by two reviewers independently, based on pre-specified eligibility criteria. Data extraction and analyses were informed by the Theoretical Domains Framework (TDF).

Results

A total of 10,992 articles were screened; 21 publications met the inclusion criteria. Data extracted were mapped to the TDF (12 of the 14 domains were used). Barriers were more commonly reported than facilitators and included lack of knowledge, lack of training and competing priorities; the most commonly reported facilitators were HPs’ sense of responsibility and willingness to provide e-cigarette cessation support. Most of the studies included were from the US and employed quantitative surveys. Most of the studies screened focused on the utility of e-cigarettes as cessation aids for combustible tobacco smoking, highlighting a gap in the interventional evidence on e-cigarette cessation.

Conclusions

More primary qualitative studies, including in Australia, are needed to understand the complexities of offering vaping cessation support. Although a range of HPs were represented in the review, further studies could analyse allied HPs’ views separately from medical professionals’ views.

Keywords: barriers, cessation support, e-cigarettes, health professionals, public health, quitting, scoping review, Theoretical Domains Framework, vaping.

KEY POINTS
  • Health professionals reported more barriers, including lack of knowledge, training, guidelines and scientific evidence on effective approaches to e-cigarette cessation, than facilitators.

  • Apart from dental hygienists, most health professionals reported a lack of time to address vaping cessation. More research exploring the roles of allied health professionals in vaping cessation separately from that of medical professionals is needed.

  • More evidence is needed to evaluate effective approaches to health professional-provided e-cigarette cessation support.

Introduction

The rising popularity of e-cigarettes in many parts of the world is a public health concern. The number of e-cigarette users was estimated to have grown globally from 25 million in 2013 to 82 million in 2021.1 E-cigarettes, also known as electronic cigarettes, electronic nicotine delivery systems or vapes, are battery-powered devices that aerosolise e-liquids, which generally contain nicotine, propylene glycol and other substances.2,3 Inhaling the aerosol is known as vaping.4 The patent for e-cigarettes dates back to 2004,5 and they were introduced into Europe and the US in 2006. Since then, the rapidly evolving and expanding e-cigarette markets have also seen escalating rates of non-smokers initiating e-cigarette use recreationally with subsequent uptake of combustible cigarette smoking.6

People who have ever used e-cigarettes at any time in their lives are known as ‘ever-vapers’. In Australia, the proportion of ever-vapers nearly tripled from 2013 to 2019,7 and 30% of secondary school students reported having ever vaped in 2022–2023.8 Globally, the prevalence of youth who have ever vaped varies between countries, for example Mexico (7.0% prevalence) compared to Switzerland (38.5% prevalence).9 Curiosity and appealing flavours were the most common reasons for initiation of e-cigarettes among Australian adolescents (12–17 years old).10 Although the long-term health impacts of e-cigarettes have not yet been ascertained, a growing body of evidence shows the detrimental consequences of vaping, including poisoning, toxicity and lung injuries.3 Nicotine-containing vaping products are also associated with a higher risk of dependence and addiction.3 To curb the emerging public health challenge, the Australian government has commenced vaping reforms by banning imports of disposable vapes,11 and by October 2024, vapes – both non-nicotine and nicotine-containing − will only be available in pharmacies where clinically appropriate, and not available legally anywhere else. These vapes will be required to meet Therapeutic Goods Administration requirements (including that they are only in mint, menthol and tobacco flavours).11

Vaping cessation is defined in several ways in the literature, from being abstinent for 30 days, to abstinent for 6 or 12 months.12 Australia’s National Tobacco Strategy 2023–2030 specifically includes the objective to ‘Encourage and assist as many people as possible who use tobacco and e-cigarettes to quit as soon as possible and prevent relapse.’13 Guides have been developed to help Australian clinicians to provide vaping cessation support.14 However, because of the paucity of evidence regarding best management of vaping cessation, these guides are based on interventions known to effectively help people quit smoking combustible tobacco.14

Given the growing prevalence of e-cigarette use and associated health concerns, it is essential to build the capacity of health professionals (HPs) to support e-cigarette cessation. HPs are often the primary point of contact when it comes to accessing tobacco or e-cigarette cessation support, representing opportunities for intervention to occur during clients’ regular visits. Previously, two systematic reviews explored HPs’ perceptions and attitudes towards e-cigarette utilisation and revealed diverse views on e-cigarette use.15,16 They also identified some common concerns regarding e-cigarettes’ long-term safety and uptake by non-smokers.15,16 However, little is known about HPs’ experiences of offering vaping cessation support. This review aimed to summarise current evidence on the facilitators and barriers to offering vaping cessation support from the perspective of various clinical HPs with client-facing roles. Due to the exploratory nature of the aim, a scoping review was chosen to map the breadth of the evidence.

Methods

Overview

We followed the Joanna Briggs Institute (JBI) Scoping Reviews methodology.17 Further information regarding the methodology is reported in Supplementary File S1. The protocol was registered on the Open Science Framework (doi:10.17605/OSF.IO/4J265).18 The content analysis was guided by the Theoretical Domain Framework (TDF), which describes 14 domains of factors that can influence HPs’ behaviours19 (see Table 1). The TDF was chosen because it provides a comprehensive explanatory structure for categorising key factors that influence HPs’ behaviour when providing vaping cessation support, bringing greater nuance and specificity to understanding the facilitators and barriers experienced by HPs. Ethics approval was not required for this scoping review as it involved the analysis of previously published data.

Table 1.Fourteen domains of the Theoretical Domains Framework (TDF) with definitions and examples.

Domains 19Definitions from the behaviour change wheel, 21 pp. 88–90Examples
1. Knowledge‘An awareness of the existence of something’Knowledge of recommendations for helping people quit vaping
2. Skills‘An ability or proficiency acquired through practice’The skills to implement vaping cessation support (e.g. skills to motivate people to quit vaping)
3. Social/professional role and identity‘A coherent set of behaviours and displayed personal qualities of an individual in a… work setting’Identifying themselves as a change agent to tackle vaping. Vaping cessation support perceived as part of their responsibilities or roles
4. Beliefs about capabilities‘Acceptance of the truth, reality or validity about an ability, talent or facility that a person can put to constructive use’Feeling confident discussing vaping cessation with clients
5. Optimism‘The confidence that things will happen for the best or that desired goals will be attained’Believing that clients will follow vaping cessation advice
6. Beliefs about consequences‘Acceptance of the truth, reality, or validity about outcomes of a behaviour in a given situation’Believing that vaping cessation will lead to better outcomes for the client
7. Reinforcement‘Increasing the probability of a response by arranging a dependent relationship, or contingency, between the response and a given stimulus’Rewards for providing vaping cessation support
Adverse consequences for not providing cessation support
8. Intentions‘A conscious decision to perform a behaviour or a resolve to act in a certain way’Intention to provide vaping cessation support to clients
9. Goals‘Mental representations of outcomes or end states that an individual wants to achieve’Having a goal to provide vaping cessation support to clients who vape
10. Memory, attention and decision processes‘The ability to retain information, focus selectively on aspects of the environment and choose between two or more alternatives’Remembering to screen the client for vaping during the consultation
11. Environmental context and resources‘Any circumstance of a person’s situation or environment that discourages or encourages the development of skills and abilities, independence, social competence and adaptive behaviour’Supportive organisational policies, or access to training, or helpful technology (e.g. prompts for HPs to screen for e-cigarette use)
12. Social influences‘Those interpersonal processes that can cause individuals to change their thoughts, feelings, or behaviours’Colleagues or peers influencing provision of vaping cessation support (e.g. discussing it, advising on it)
13. Emotion‘A complex reaction pattern, involving experiential, behavioural, and physiological elements, by which the individual attempts to deal with a personally significant matter or event’Strong feelings about vaping and potential harms.
Comfort level when counselling clients
14. Behavioural regulation‘Anything aimed at managing or changing objectively observed or measured actions’Systems to track and evaluate the progress of the client in their attempt to quit or systems to help HPs monitor if they are providing support effectively

Search strategy

A preliminary search of the Cochrane Database of Systematic Reviews and Google Scholar was conducted, and no current or underway systematic reviews or scoping reviews on the topic were identified. Search strategies were developed based on the Population-Concept-Context framework and initially piloted in MEDLINE. Expert advice from a librarian facilitated the refinement of the strategy. The search was adapted and run in five additional databases to MEDLINE: CINAHL, PubMed, PsycINFO, EMBASE and SCOPUS, and limited to peer-reviewed articles published after 2003 (the first appearance of e-cigarettes). Supplementary File S2 contains the final MEDLINE search strategy. Searches were conducted from 9 to 10 October 2023 and repeated on 17 April 2024. Reference lists of all included papers were reviewed to identify additional papers.

Inclusion and exclusion criteria

Inclusion and exclusion criteria are specified in Fig. 1. We were exclusively interested in studies that specifically addressed e-cigarette cessation support and therefore excluded papers that considered e-cigarettes as a cessation tool for combustible cigarettes and did not further explore e-cigarette cessation. Papers mentioning both e-cigarette and combustible cigarette cessation were included if the barriers or facilitators to offering vaping cessation support were reported separately. We included papers from countries with similar health systems to Australia, including similarities in HP registration systems, per capita expenditures on health and the ratio of medical practitioners per capita.20 Grey literature and unpublished studies were excluded due to resource constraints.

Fig. 1.

Population-Concept-Context guided inclusion and exclusion criteria.


PU24013_F1.gif

Eligibility screening

All retrieved references were uploaded to Covidence software22 and independently screened by two reviewers based on the eligibility criteria. Two-staged screening (title and abstract followed by full text) was undertaken after pilot-testing. There were four reviewers in the team (all authors of this paper). Each paper was assessed for inclusion or exclusion by two reviewers (in various pairings). All disagreements at each stage were resolved through weekly online meetings where reviewers clarified their decisions, and papers were discussed until a consensus was reached.

Data extraction

Before data extraction, definitions and examples for each of the TDF domains were developed (Table 1). Two data extraction templates were developed, pilot-tested and refined (Supplementary Files S3 and S4). Initially, one reviewer extracted information regarding each publication’s characteristics, including aim, study design, population and country (Supplementary File S3). Data relevant to each TDF domain were extracted and categorised into either facilitators or barriers (Supplementary File S4). Each paper and extracted data were examined by two reviewers. Disagreements were resolved through discussion.

Data analysis

Deductive content analysis23 was used with the TDF serving as an organising matrix. The raw data in each domain were summarised into descriptive paragraphs by one reviewer and cross-checked by another to ensure that all relevant facilitators and barriers extracted were included in the summary concisely. Any issues arising were discussed among the reviewing team through weekly meetings.

Results

Overview

The search identified 16,404 papers initially and an additional 2071 papers in April 2024. Following duplicate removal and screening by title, abstract and full-text, 21 studies were included in the final review (Fig. 2). Most of the included studies were from the US (n = 18), with one from Australia, were quantitative survey studies (n = 14), and were published between 2020 and 2024 (n = 19). Nine studies surveyed HPs working within a range of settings that included one or more of: academic primary care settings, outpatient settings, inpatient settings, public health practices or private practices.2432 Six studies involved HPs working exclusively in community healthcare settings,3338 three focused on HPs working in inpatient settings only (hospital or academic primary care centres)3941 and one focused on clinical staff in outpatient primary care clinics.42 Physicians, nurses, social workers, pharmacists, counsellors, psychologists, dentists, oral hygienists and physiotherapists were the HPs in the included studies. Data from the papers were mapped to 12 of the 14 domains, with more barriers than facilitators in most domains (Table 2).

Fig. 2.

Preferred Reporting of Items for Systematic Reviews and Meta-Analysis Extension for Scoping Reviews flow diagram.


PU24013_F2.gif
Table 2.Characteristics of each study, including barriers and facilitators, mapped to each domain of the Theoretical Domains Framework.

First author (year)CountryPopulation AStudy designTheoretical Domains Framework domains B
1234567891011121314
Cano Rodriguez et al. (2021)USAdolescent clinic staffRetrospective chart review
Chin et al. (2022)USPaediatric endocrinology teamQuantitative survey
Craig et al. (2022)USObstetrics and gynaecology providersQuantitative survey
Dyson et al. (2023)UKStop-smoking advisorsInterviews
Fielding-Singh et al. (2020)US (global participants)Primary care staffQuantitative survey
Gorukanti et al. (2022)USAdolescent healthcare cliniciansQuantitative survey
Gorzkowski et al. (2016)USPaediatric cliniciansFocus groups
Hartwell et al. (2020)UKStop-smoking advisorsInterviews
Heinly et al. (2023)USPaediatric physiciansQuantitative survey
Holden et al. (2023)USNursesQuantitative survey
Kovach et al. (2021)USPrimary care staffInterviews and focus groups
McGee et al. (2021)USPrimary care staffQuantitative survey
Metcalf et al. (2022)USPrimary and non-primary care staffQuantitative survey
Mungia et al. (2021)USDental practitionersFocus groups
Mungia et al. (2022)USDental practitionersQuantitative survey
Nowlin et al. (2018)USDentistsInterviews
Oliver et al. (2022)USPrimary care staffQuantitative survey
Rahman et al. (2024)AustraliaPrimary care staffInterviews and co-design workshops
Sundstrom et al. (2023)USDental hygienistsQuantitative survey
Wilson et al. (2021)USPhysical therapistsQuantitative survey
Zhou et al. (2020)USPrimary care physicians, allergists and pulmonologistsQuantitative survey
Total number of articles (N = 21)1611911270734174110

● = Barrier, ○ = Facilitator, ◉ = Barrier and Facilitator.

The structure of this table follows table 2 in Caltabiano et al.45

A Full list of health professionals covered can be found in the Supplementary File S3. Primary care staff can include physicians, nurses, social workers, physician assistants, pharmacists, psychologists and counsellors.
B TDF domains: 1. Knowledge; 2. Skills; 3. Social/professional role and identity; 4. Beliefs about capabilities; 5. Optimism; 6. Beliefs about Consequences; 7. Reinforcement; 8. Intentions; 9. Goals; 10. Memory, attention and decision processes; 11. Environmental context and resources; 12. Social influences; 13. Emotion; 14. Behavioural regulation.

‘Knowledge’, ‘Skills’ and ‘Environmental context and resources’ (Domains 1, 2 and 11)

Barriers

Lack of knowledge and information about e-cigarettes were the most common barriers identified in the Knowledge domain. Reported knowledge deficits included general knowledge about e-cigarettes (types, terminology and chemical content), and the prevalence, harm and health effects of e-cigarette use and associated laws and regulations. Other barriers included a lack of knowledge about effective ways to support vaping cessation (initiating screening and cessation counselling, approaches to address vaping, where and how to refer clients for cessation support) and the differences between addressing vaping and other substance use. One study highlighted a dearth of available scientific information about e-cigarettes, including long-term harms and effective treatment.43 Some HPs obtained their knowledge from channels that do not always contain evidence-based information (e.g. popular media, advertising or Internet searches).28,43

Similarly, lack of experience and practice in helping clients quit e-cigarettes or using motivational interviewing techniques were the common barriers in the Skills domain.26,35,44 HPs self-identified training needs within a broad spectrum of clinical skills necessary to support vaping cessation, including assessing e-cigarette use, counselling and motivating clients to quit, recommending treatments and referring clients for quitting support. The following vaping-related communication issues were also highlighted: challenges in communicating the long-term effects of e-cigarette use and difficulties in staying up-to-date with the evolving terminology used to describe e-cigarettes.

Knowledge and skills gaps were related to barriers in the Environmental context and resources domain and included lack of training, scientific information and clear evidence about e-cigarette cessation.24,25,28,36,38,40 HPs also felt there were no policies, recommendations or clinical guidelines on vaping cessation interventions (for example, calculating the dosage of nicotine replacement therapy) to rely on, meaning they obtained knowledge from the news media or their peers and they needed to make decisions based on their clinical judgement or instincts. This contributed to their hesitancy in addressing e-cigarette use. Additionally, competing priorities under time constraints were barriers to e-cigarette cessation counselling in three studies, with two other studies highlighting that e-cigarette cessation counselling limits HPs’ capacity to ask other health-related questions in a consultation. Furthermore, some multifaceted barriers existed at the organisational level. For example, some stop-smoking services were unable to support vaping cessation for ex-smokers, who then became regular vapers, due to limited funding and capacity. Systemic difficulties included that screening questions about tobacco use did not ask about e-cigarettes and that incorporating e-cigarette screening tools into electronic health records (EHRs) was challenging. One paper from Australia highlighted that the rapidly changing regulatory environment contributed to clients’ reluctance to disclose their vaping and left HPs feeling unprepared to address vaping.44

Facilitators

In contrast to the majority of other HPs who reported a lack of time to screen or counsel for e-cigarette cessation,26,28,40 more than half the dental hygienists surveyed in one study reported that they had the time and the choice to ask adolescent clients about e-cigarette use.31

Most HPs were interested in learning more about e-cigarettes, and short courses were found to improve knowledge and skills about e-cigarette devices and approaches to cessation. Although most studies highlighted deficits in knowledge of e-cigarettes, three studies reported that HPs did have some knowledge about e-cigarettes, including their function, chemical content, likelihood of containing nicotine and common health concerns, such as their addictive nature, and oral and neurological health consequences. Three studies reported that HPs had medium to high levels of knowledge about e-cigarettes and their health effects (measured through self-assessment or correct/incorrect answers to multiple-choice knowledge questions).30,31,41 However, one study found that despite self-rating their knowledge as ‘somewhat knowledgeable’, pulmonologists only answered 33% of knowledge questions regarding e-cigarettes accurately.41

HPs often reported that more resources were needed, including training, virtual shared resources, educational material for themselves and their clients, scripts, vaping lingo dictionaries, screening tools, more scientific information from credible sources, and a standardised curriculum in general practice and residency training and in ongoing education to address e-cigarette use. An online interactive program in the US employing presentations, case discussions and role-plays was found to improve physicians’ screening and treatment practices. Attending training also helped nurses develop motivational interviewing expertise using the Screening, Brief Intervention and Referral to Treatment skillset, with a resultant self-reported improvement in skills. Most importantly, the inclusion of specific e-cigarette screening questions in the EHR system was identified as the most effective way to increase screening rates when compared to education and training.39 This EHR built-in screening intervention was also found to be brief. Regardless of clients’ vaping status, it did not lengthen the duration of clients’ visits or cost extra time for clinicians.

Finally, in the Environmental context and resources domain some HPs reported that they would still help clients quit vaping while working with a finite budget and capacity.34 Some HPs also expressed interest in updating e-cigarette policies.37

‘Social/professional role and identity’ (Domain 3)

Barriers

Discussing vaping with clients was not universally accepted as core practice for HPs. An action-intention gap was highlighted in a study with physiotherapists, where 73% believed that they had a role in addressing vaping but only 3% reported that they routinely addressed it.32

Facilitators

Most HPs reported a responsibility to screen for e-cigarette use, counsel or intervene with those who use e-cigarettes.24,30,32,35,38 This sense of responsibility contributed to actions like banning indoor vaping in their practices, despite the absence of specific anti-vaping policies.37 Others reported that assigning responsibilities to specific members of the (general practice) team could help HPs understand how they could contribute to e-cigarette cessation.36

‘Beliefs about capabilities’ and ‘Emotion’ (Domains 4 and 13)

Barriers

Most HPs did not feel confident or comfortable addressing e-cigarette use, including answering questions, explaining known harms, detecting clinical signs of e-cigarette use or using cessation support techniques (offering cessation support, asking about vape use, providing education and counselling about e-cigarette cessation). Some studies also explored the causes and effects of HPs’ lack of confidence. Paediatricians had varying levels of confidence, and those who reported less confidence attributed this to a lack of robust research about the health impacts and safety of e-cigarettes.28 A lack of formal training and continuing education on e-cigarettes contributed to low levels of confidence across HPs working with adolescents.24 Low screening rates and infrequent conversations about e-cigarette use may reflect HPs’ lack of confidence in addressing the topic. Additionally, some nurses struggling to adapt to telehealth because of COVID-19 reported that this change in care delivery impeded their ability to meaningfully connect with clients, resulting in forgetting how to ask or feeling uncomfortable about asking about e-cigarette use.

Facilitators

Two studies reported that over half of primary care physicians, nurse practitioners and dental hygienists felt confident in discussing e-cigarettes or asking about e-cigarette use. Respondents from two studies (physicians, social workers and nurses who worked closely with adolescents) reported feeling somewhat confident in discussing e-cigarettes with their patients or clients. Pulmonologists were also relatively comfortable in counselling their patients to quit e-cigarette use. Those who felt confident stated that training (and resources in the consultation room) on screening, brief intervention and referral to treatment improved their confidence. Additionally, some HPs reported that their abilities to offer effective e-cigarette cessation counselling would improve with more research, clinical guidelines, and client and family resources.

‘Optimism’ and ‘Beliefs about the consequences’ (Domains 5 and 6)

Barriers

Some HPs believed that their advice would not lead to behaviour change among clients. One study revealed a concern that even if providers were trained about screening for e-cigarettes, only 11% of them were optimistic that their advice would help their clients stop using e-cigarettes.25 Additionally, some HPs believed that providing e-cigarette cessation advice to clients who were not contemplating quitting would be perceived negatively by their clients and could cause patients to ‘shut down’, although this goes against recommended practice.28,44 They emphasised that clients needed to be willing to make changes for advice to be effective.28

Facilitators

Beliefs about the effectiveness of cessation counselling were also considered facilitators. Two studies reported that most HPs believed that providing counselling was effective for e-cigarette cessation38,42 and that screening for use was important.24,42 One study reported that the training provided was perceived to be useful and there was optimism that it would result in increased support for cessation. Some dental hygienists considered that asking about e-cigarette use and documenting it in the medical records at every appointment would create an opportunity for education about the oral harms of e-cigarettes.31

‘Intentions’ (Domain 8)

Barriers

Two papers found that some providers had little intention of asking their clients about vaping.

Facilitators

In most studies, HPs expressed a willingness to provide vaping cessation support in general25,26,31,35,38,46 and more specifically by asking about and assessing e-cigarette use, modifying treatment plans, increasing client communication,26 conducting motivational interviewing,35 discussing risks of vaping,38 adding new skills into client care26 or by using the 5As used in combustible tobacco cessation support (Ask, Advise, Assess, Assist and Arrange follow-up).31,47 Some of these intentions to provide vaping cessation support were increased by training received.26

‘Goals’ (Domain 9)

Barriers

Barriers related to goals were described in one paper reporting on a project undertaken by a General Practitioner (GP) clinic aiming to increase implementation of e-cigarette cessation support in the clinic.36 One of the perceived challenges was that the project goals tended to focus more on the system and process rather than client care or recent vaping trends and, therefore, might not engage other key stakeholders.36

Facilitators

Facilitators in the Goals domain identified in the paper describing the GP clinic project included creating a strong project vision to enable multiple stakeholders’ engagement that was informed by the local prevalence of e-cigarette use, clients’ narratives or HPs’ personal experiences.36

‘Memory, attention and decision processes’ (Domain 10)

Facilitators

HPs reported that certain client characteristics could prompt screening for e-cigarette use,25 including the odour of tobacco or sighting the client’s vaping device.25 Others reported that incorporating screening questions into the EHR would prompt them to ask about and document e-cigarette use consistently.36,39

‘Social influences’ (Domain 12)

Barriers

HPs highlighted two barriers: (1) influences from their colleagues and (2) gaps in engaging their peers in wider contexts. Two studies discussed how colleagues’ behaviours or beliefs affected how vaping was addressed. In one, only half the dental hygienists surveyed reported receiving support from their supervisors or dentists to screen for e-cigarette use.31 The lack of social pressure and influence from friends, colleagues and supervisors contributed to HPs’ infrequent screening for e-cigarette use, especially when competing priorities arose during the appointment.31 Staff reported challenges in a UK stop-smoking service where e-cigarettes were provided for smoking cessation when the ultimate goal was quitting both smoking and vaping.33 Challenges included conflicting advice provided by different advisors and some undesirable social influences from the e-cigarette technical support staff who were also e-cigarette users, impacting service delivery.33 In a study with family medicine practices, HPs identified missed opportunities to influence other HPs to incorporate e-cigarette cessation into their practice as most had minimal experience working with HPs outside their immediate circle.36

Facilitators

Two studies described social factors that could potentially enable HPs to incorporate e-cigarette cessation into their practices: leadership through influence and normative beliefs.31,36 HPs in GPs practices acknowledged that incorporating e-cigarette cessation into practice required making changes to the system and, thus, the influence of leadership was essential to affect this change.36 Some dental hygienists stated that most of their peers asked about e-cigarette use and many considered that being like their colleagues was extremely important,31 reinforcing the importance of positive social influence in taking this first step in identifying people who needed cessation support.

Discussion

This scoping review synthesised data from 21 studies and mapped the relevant facilitators and barriers experienced by HPs working in a range of practice settings (academic primary care settings, outpatient settings, inpatient settings, community health, private practice) to 12 domains of the TDF. More barriers were identified than facilitators. A recurring theme among barriers was that HPs reported lacking knowledge and training about e-cigarettes and insufficient scientific evidence on effective approaches to e-cigarette cessation and the long-term impacts of vaping, potentially resulting in lower confidence in addressing e-cigarette use.2426,28,29,3538,4042,46 Lack of knowledge and confidence about e-cigarettes was also seen in a previous systematic review that explored GPs’ knowledge and views on prescribing e-cigarettes for smoking cessation as e-cigarettes are relatively new and the evidence base is still growing. Having competing priorities was also commonly reported as a barrier. This aligned with other studies where heavy workloads and time constraints were frequently mentioned as barriers to combustible tobacco cessation care in hospital and primary care settings.48,49 Despite the diverse practice settings reported, a recurring theme identified as a facilitator was that most HPs felt responsible for addressing e-cigarette use and were interested in learning more about e-cigarettes to offer cessation support.2426,3032,35,38,46 Based on the Theory of Planned Behaviour, strong behavioural intention is more likely to lead to behaviour change.50 Several organisational resources, such as short-course training, clinical guidelines, and educational materials, were highlighted as beneficial in enabling HPs to provide vaping cessation counselling.28,30,33,35,36,39,46 The implementation of new vaping laws will require Australian community pharmacists to provide vaping cessation support to consumers with nicotine addiction, and suites of training resources and guidelines to address pharmacists’ need for evidence-based practice have been developed or are being updated.44,51 In New South Wales, all HPs with client-facing roles are encouraged to provide vaping cessation using brief interventions via the ‘Ask, Advise, Help’ model and to record cessation support offered and accepted.14 Inclusion of standardised screening tools in EHR systems to include prompts to remind HPs to screen for e-cigarette use and provide vaping cessation support would be beneficial as identified by HPs in the included studies.24,28,35,39

During the screening process, gaps in the wider literature were also identified. Firstly, many studies we excluded explored e-cigarettes’ potential as cessation aids for combustible tobacco smoking but focused very little on e-cigarette cessation. This highlights that further studies are needed to investigate effective approaches to e-cigarette cessation, including robust trials tailored to different contexts and age groups. Regarding e-cigarette use by young people, several papers focused on HPs with paediatric practices and identified resources HPs needed to provide vaping cessation support to young people, including prompting through the EHR, evidence-based information and training.27,28,39,40 It is important that these resources address the provision of vaping cessation support in developmentally appropriate ways and that they focus on youth-identified issues regarding vaping cessation support (e.g. alternative strategies to vaping for stress management, concerns about confidentiality and how to deal with attention and concentration difficulties).52 Most articles included in this review were quantitative studies, suggesting that more qualitative studies are needed to explore firsthand accounts of HPs’ experiences in offering vaping cessation. Despite efforts to include a diverse range of HPs during the search, the views of some allied HPs, such as psychologists or counsellors, were not reported separately from medical professionals. Given that medical and nursing staff often report time constraints and having to prioritise acute issues, the roles of allied HPs who may see clients for longer periods of time, or more frequently for chronic health issues, could be explored separately from medical professionals.

Strengths

To our knowledge, this paper is the first scoping review to explore facilitators and barriers to vaping cessation support. The rigorous methodology employed included adherence to the JBI methodology, the conducting of a comprehensive search and following a prespecified protocol. We also covered a diverse range of HPs, leading to findings on dental and physiotherapist professionals whose roles in e-cigarette cessation were previously less well explored. Additionally, utilising the strength of a team in reviewing all the articles allowed productive discussion to bring different perspectives and experiences, enriching the understanding of the data.

Limitations

Systematic assessments of bias and quality were not conducted in this scoping review because this is not part of the JBI methodology for scoping reviews and the primary purpose was to map the breadth of the evidence.17 Additionally, due to resource constraints, we excluded grey literature and studies from countries that do not have similar healthcare systems to Australia, resulting in all included studies being from Australia, the US and the UK. The inclusion of studies from other countries would provide a broader picture of barriers and facilitators encountered by HPs in other healthcare systems.

Conclusion

This review summarised what is currently known in the literature regarding the barriers and facilitators experienced by HPs when offering vaping cessation support. Lack of knowledge, training, inclusion of vaping in the EHR and competing priorities were the most frequently reported barriers; whereas the sense of responsibility, intention to provide e-cigarette cessation support and several environmental resources were the frequently reported facilitators. This review also calls for further interventional studies to evaluate the effectiveness of e-cigarette cessation approaches and more qualitative studies to understand the complexity of offering e-cigarette cessation support from a diverse range of HPs and settings including in Australia.

Supplementary material

Supplementary material is available online.

Data availability

The data supporting the findings of this study are available within the article and its supplementary materials.

Conflicts of interest

No potential conflicts of interest concerning the research, authorship and/or publication of this article.

Declaration of funding

No funding was received.

Peer review and provenance

Externally peer reviewed, not commissioned.

Acknowledgements

This research project was undertaken as part of LT’s degree of Master of Public Health, at the University of Sydney. We would like to acknowledge the research supervisors for ongoing support: MP, JL and LB. We thank the librarian team at the University of Sydney for offering insights to refine search strategies and the unit coordinators for sharing feedback.

Author contributions

The study was conceived by MP, JL and LB. LT developed search questions and conducted literature searches. LT drafted the search strategy with input from MP, JL, LB and the university librarian team. All authors contributed to the study design, eligibility screening, data extraction and data analysis. LT drafted the manuscript, which was reviewed and edited by MP, JL and LB.

Authorship inclusivity and diversity statement

One or more of the manuscript authors self-identifies as a member of an underrepresented culturally and/or linguistically diverse minority. The authorship of the manuscript includes consumers and/or practitioners who are the subject of the paper.

References

Jerzyński T, Stimson GV, Shapiro H, Król G. Estimation of the global number of e-cigarette users in 2020. Harm Reduct J 2021; 18(1): 109.
| Crossref | Google Scholar | PubMed |

Hess IM, Lachireddy K, Capon A. A systematic review of the health risks from passive exposure to electronic cigarette vapour. Public Health Res Pract 2016; 26(2): 2621617.
| Crossref | Google Scholar | PubMed |

Banks E, Yazidjoglou A, Brown S, Nguyen M, Martin M, Beckwith K, et al. Electronic cigarettes and health outcomes: umbrella and systematic review of the global evidence. Med J Aust 2023; 218(6): 267-75.
| Crossref | Google Scholar | PubMed |

Dyson J, Bhatnagar M, Skinner J, Crooks M. Helping the quitters quit: A systematic review and narrative synthesis of the barriers and facilitators to e-cigarette cessation and the support that is needed. Patient Educ Couns 2022; 105(6): 1402-10.
| Crossref | Google Scholar | PubMed |

Franck C, Budlovsky T, Windle SB, Filion KB, Eisenberg MJ. Electronic Cigarettes in North America: History, Use, and Implications for Smoking Cessation. Circulation (New York, NY) 2014; 129(19): 1945-52.
| Crossref | Google Scholar | PubMed |

Al-Hamdani M, Manly E. Smoking cessation or initiation: The paradox of vaping. Prev Med Rep 2021; 22: 101363.
| Crossref | Google Scholar | PubMed |

Greenhalgh E, EM B, Jenkins S, Scollo M. 18.3 Prevalence of e-cigarette use. In: Greenhalgh E, Scollo M, Winstanley M, editors. Tobacco in Australia: Facts & issues. Melbourne: Cancer Council Victoria; 2023. Available at https://www.tobaccoinaustralia.org.au/chapter-18-e-cigarettes/18-3-legal [cited 15 April 2025].

Scully M, Bain E, Koh I, Wakefield M, Durkin S. Australian secondary school students’ use of tobacco and e-cigarettes – 2022–2023. Cancer Council Victoria; 2023. Available at https://www.health.gov.au/resources/publications/australian-secondary-school-students-use-of-tobacco-and-e-cigarettes-2022-2023?language=en [cited 22 April 2025].

Yoong SL, Hall A, Leonard A, McCrabb S, Wiggers J, Tursan d’Espaignet E, et al. Prevalence of electronic nicotine delivery systems and electronic non-nicotine delivery systems in children and adolescents: a systematic review and meta-analysis. Lancet Public Health 2021; 6(9): e661-73.
| Crossref | Google Scholar | PubMed |

10  Thoonen KAHJ, Jongenelis MI. Motivators of e-cigarette use among Australian adolescents, young adults, and adults. Soc Sci Med (1982) 2024; 340: 116411.
| Crossref | Google Scholar | PubMed |

11  The Department of Health and Aged Care. Disposable vape imports now banned Australia. 2024. Available at https://www.health.gov.au/ministers/the-hon-mark-butler-mp/media/disposable-vape-imports-now-banned [cited 15 April 2025].

12  Kundu A, Seth S, Felsky D, Moraes TJ, Selby P, Chaiton M. A Systematic Review of Predictors of Vaping Cessation Among Young People. Nicotine Tob Res 2025; 27(2): 169-178.
| Crossref | Google Scholar | PubMed |

13  Department of Health and Aged Care. National Tobacco Strategy 2023–2030. Canberra: Commonwealth Department of Health and Aged Care; 2023. Available at https://www.health.gov.au/resources/publications/national-tobacco-strategy-2023-2030?language=en [cited 22 April 2025].

14  NSW Ministry of Health. Guide to Support Young People to Quit E-Cigarettes. St Leonards: NSW Ministry of Health; 2024. Available at https://www.health.nsw.gov.au/tobacco/Pages/e-cigarette-young-people-guide.aspx [cited 22 April 2025].

15  Selamoglu M, Erbas B, Kasiviswanathan K, Barton C. General practitioners’ knowledge, attitudes, beliefs and practices surrounding the prescription of e-cigarettes for smoking cessation: a mixed-methods systematic review. BMC Public Health 2022; 22(1): 2415.
| Crossref | Google Scholar | PubMed |

16  Erku DA, Gartner CE, Morphett K, Steadman KJ. Beliefs and Self-reported Practices of Health Care Professionals Regarding Electronic Nicotine Delivery Systems: A Mixed-Methods Systematic Review and Synthesis. Nicotine Tob Res 2020; 22(5): 619-29.
| Crossref | Google Scholar | PubMed |

17  Peters MDJ, Godfrey C, McInerney P, Munn Z, Tricco AC, Khalil H. Chapter 11: Scoping Reviews (2020 version). In: Aromataris E, Munn Z, editors. JBI Reviewer’s Manual. JBI; 2020. 10.46658/JBIMES-20-12

18  Tan CL, Passey M, Longman J, Barnes L. Exploring the Facilitators and Barriers Experienced by Health Professionals in Offering Vaping Cessation Support - A Scoping Review Proposal. Open Science Framework. 2023. 10.17605/OSF.IO/4J265

19  Atkins L, Francis J, Islam R, O’Connor D, Patey A, Ivers N, et al. A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems. Implement Sci 2017; 12(1): 77.
| Crossref | Google Scholar | PubMed |

20  Medical Council of New Zealand. Comparable health system criteria: Medical Council of New Zealand. 2019. Available at https://www.mcnz.org.nz/registration/getting-registered/registration-policy/comparable-health-system-criteria/ [cited 26 September 2023].

21  Michie S, Atkins L, West R. The Behaviour Change Wheel: A Guide to Designing Interventions. Great Britain: Silverback Publishing; 2014.

22  Covidence systematic review software. Veritas Health Innovation Melbourne, Australia. 2024. Available at www.covidence.org [cited 15 April 2025].

23  Elo S, Kyngäs H. The qualitative content analysis process. J Adv Nurs 2008; 62(1): 107-15.
| Crossref | Google Scholar | PubMed |

24  Chin A, Zonfrillo MR, Heinly A, Ford SR, Quintos JB, Topor LS. Screening and counseling for nicotine use in youth with diabetes. Pediatr Diabetes 2022; 23(1): 157-64.
| Crossref | Google Scholar | PubMed |

25  Craig M, Tamirisa A, Madhavan R, Jochum E, Cohen A, Zoorob D. Vaping in pregnancy: A geographically focused assessment of OBGYN provider knowledge regarding the safety and usage of electronic nicotine delivery systems. Clin Exp Obstet Gynecol 2022; 49(2): 31.
| Crossref | Google Scholar |

26  Fielding-Singh P, Brown-Johnson C, Oppezzo M, Das S, Jackler R, Prochaska JJ. E-Cigarettes: Harmful or Harm-Reducing? Evaluation of a Novel Online CME Program for Health Care Providers. J Gen Intern Med 2020; 35(1): 336-40.
| Crossref | Google Scholar | PubMed |

27  Gorukanti AL, Kimminau KS, Tindle HA, Klein JD, Gorzkowski J, Kaseeska K, et al. Cross-sectional online survey of clinicians’ knowledge, attitudes and challenges to screening and counselling adolescents and young adults for substance use. BMJ Open 2022; 12(11): e059019.
| Crossref | Google Scholar | PubMed |

28  Gorzkowski JA, Whitmore RM, Kaseeska KR, Brishke JK, Klein JD. Pediatrician Knowledge, Attitudes, and Practice Related to Electronic Cigarettes. J Adolesc Health 2016; 59(1): 81-6.
| Crossref | Google Scholar | PubMed |

29  Metcalf M, Rossie K, Stokes K, Tanner B. Health Care Professionals’ Clinical Skills to Address Vaping and e-Cigarette Use by Patients: Needs and Interest Questionnaire Study. JMIR Form Res 2022; 6(4): e32242.
| Crossref | Google Scholar | PubMed |

30  Oliver AP, Bell LA, Agley J, Bixler K, Hulvershorn LA, Adams ZW. Examining the Efficacy of Project ECHO to Improve Clinicians’ Knowledge and Preparedness to Treat Adolescent Vaping. Clin Pediatr 2022; 61(12): 869-78.
| Crossref | Google Scholar | PubMed |

31  Sundstrom RM, Boyd LD, Martell KM, Vineyard J. Dental Hygienists Knowledge, Beliefs, and Intentions Regarding Asking Adolescents About Electronic Nicotine Delivery Systems Use. J Adolesc Health 2023; 73: 1053-60.
| Crossref | Google Scholar | PubMed |

32  Wilson CM, Lucado AM, Wendland DM, Taylor DWM, Black B. Health Promotion, Wellness, and Prevention Practice in Oncologic Physical Therapy: A Survey Study. Rehabil Oncol 2021; 39(3): E51-7.
| Crossref | Google Scholar |

33  Dyson J, Skinner J, Crick J, Crooks MG. Designing an intervention to help the quitters quit: A qualitative, intervention co-design study. PEC Innov 2023; 2: 100141.
| Crossref | Google Scholar | PubMed |

34  Hartwell G, Egan M, Petticrew M. Understanding decisions to use e-cigarettes or behavioural support to quit tobacco: a qualitative study of current and ex-smokers and stop smoking service staff. Addiction (Abingdon, England) 2020; 115(3): 518-26.
| Crossref | Google Scholar | PubMed |

35  Holden J, Simerson D. Screening, brief intervention and referral to treatment (SBIRT) by nurses to college students who use electronic cigarettes. J Am Coll Health 2023; 71(5): 1361-6.
| Crossref | Google Scholar | PubMed |

36  Kovach KA, Peterson R, Bharati R, Istas K, Monroe M. Co-creating opportunities to incorporate cessation for electronic nicotine delivery systems in family medicine - a qualitative program evaluation. BMC Fam Pract 2021; 22(1): 169.
| Crossref | Google Scholar | PubMed |

37  Nowlin JP, Lee JGL, Wright WG. Implementation of Recommended Tobacco Cessation Systems in Dental Practices: A Qualitative Exploration in Northeastern North Carolina. J Dent Educ 2018; 82(5): 475-82.
| Crossref | Google Scholar | PubMed |

38  Mungia R, Case K, Valerio MA, Mendoza M, Taverna M, de la Rosa EM, et al. Development of an E-Cigarettes Education and Cessation Program: A South Texas Oral Health Network Study. Health Promot Pract 2021; 22(1): 18-20.
| Crossref | Google Scholar | PubMed |

39  Cano Rodriguez Z, Chen Y, Siegel JH, Rousseau-Pierre T. Vaping: Impact of Improving Screening Questioning in Adolescent Population: A Quality Improvement Initiative. Pediatr Qual Saf 2021; 6(1): e370.
| Crossref | Google Scholar | PubMed |

40  Heinly A, Baird J, Riese A. Screening and Counseling Practices for Parental Combustible Versus Electronic Cigarette Use in Pediatric Primary Care: A Pilot Study. Clin Pediatr 2023; 62(10): 1169-75.
| Crossref | Google Scholar | PubMed |

41  Zhou SS, Baptist AP. Electronic cigarettes: How confident and effective are allergists, pulmonologists, and primary care physicians in their practice behavior? Allergy Asthma Proc 2020; 41(3): 192-7.
| Crossref | Google Scholar | PubMed |

42  McGee LU, Parker S, Bulsara S, Escobar B, Kline KN, Jibaja-Weiss ML, et al. Adolescent electronic cigarette counselling: knowledge, attitudes and perceived barriers among clinical staff in a primary care setting. J Eval Clin Pract 2021; 27(6): 1398-402.
| Crossref | Google Scholar | PubMed |

43  Longman JM, Adams CM, Johnston JJ, Passey ME. Improving implementation of the smoking cessation guidelines with pregnant women: How to support clinicians? Midwifery 2018; 58: 137-44.
| Crossref | Google Scholar | PubMed |

44  Rahman N, Sebar B, Sofija E. ‘It’s the wild west out there’: A qualitative study of the views and preparedness of health professionals in helping young adult e-cigarette users to quit. Nicotine Tob Res 2024; 26: 1538-44.
| Crossref | Google Scholar | PubMed |

45  Caltabiano P, Bailie J, Laycock A, Shea B, Dykgraaf SH, Lennox N, et al. Identifying barriers and facilitators to primary care practitioners implementing health assessments for people with intellectual disability: a Theoretical Domains Framework-informed scoping review. Implement Sci Commun 2024; 5(1): 39.
| Crossref | Google Scholar | PubMed |

46  Mungia R, Mexquitic M, Case K, Atique M, Jones B, MacCarthy D, et al. Implementation of a youth and young adult e-cigarette cessation program within a dental clinic setting: A SToHN feasibility study. Tex Dent J 2022; 139(9): 542-54.
| Google Scholar | PubMed |

47  NSW Ministry of Health. NSW clinical guidelines for the management of substance use during pregnancy, birth and the postnatal period. Sydney: NSW Ministry of Health; 2014 Available at https://www.health.nsw.gov.au/aod/professionals/Pages/substance-use-during-pregnancy-guidelines.aspx [cited 15 April 2025].

48  Russell L, Whiffen R, Chapman L, Just J, Dean E, Ugalde A, et al. Hospital staff perspectives on the provision of smoking cessation care: a qualitative description study. BMJ Open 2021; 11(5): e044489.
| Crossref | Google Scholar | PubMed |

49  Westmaas JL, Kates I, Makaroff L, Henson R. Barriers to helping patients quit smoking: Lack of knowledge about cessation methods, E-cigarettes, and why nurse practitioners and physician assistants can help. Public Health Pract 2023; 6: 100409.
| Crossref | Google Scholar | PubMed |

50  Conner M, Norman P. Understanding the intention-behavior gap: The role of intention strength. Front Psychol 2022; 13: 923464.
| Crossref | Google Scholar | PubMed |

51  Therapeutic Goods Administration (TGA). Vapes: information for pharmacists. Department of Health and Aged Care, Commonwealth of Australia; 2024. Available at https://www.tga.gov.au/products/unapproved-therapeutic-goods/vaping-hub/vapes-information-pharmacists [cited 22 April 2025].

52  Bold K, Kong G, Cavallo D, Davis D, Jackson A, Krishnan-Sarin S. School-based E-cigarette cessation programs: What do youth want? Addict Behav 2022; 125: 107167.
| Crossref | Google Scholar | PubMed |